Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlott Brunmark

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pulmonary Pharmacology & Therapeutics|September 15, 2012
Altered lung function relates to inflammation in an acute LPS mouse modelHanna Falk Håkansson, Amir Smailagic, Charlott Brunmark, et al.
Journal of Neuroimmunology|September 13, 2002
The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitisCharlott Brunmark, Anna Runström, Lennart Ohlsson, et al.
Journal of Medical Genetics|July 12, 2011
Fibroblast growth factor 10 haploinsufficiency causes chronic obstructive pulmonary diseaseJoakim Klar, Peter Blomstrand, Charlott Brunmark, et al.
International Journal of Pharmaceutics|April 12, 2021
Biodistribution of fluorescence-labelled EGF protein from slow release NanoZolid depots in mouseStefan Grudén, Charlott Brunmark, Bo Holmqvist, et al.
Cell Communication and Signaling : CCS|February 7, 2025
Nano-XRF of lung fibrotic tissue reveals unexplored Ca, Zn, S and Fe metabolism: a novel approach to chronic lung diseasesBryan Falcones, Maik Kahnt, Ulf Johansson, et al.
Plos One|August 21, 2012
Transient receptor potential ankyrin 1 channel localized to non-neuronal airway cells promotes non-neurogenic inflammationRomina Nassini, Pamela Pedretti, Nadia Moretto, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pulmonary Pharmacology & Therapeutics|September 15, 2012
Altered lung function relates to inflammation in an acute LPS mouse modelHanna Falk Håkansson, Amir Smailagic, Charlott Brunmark, et al.
Journal of Neuroimmunology|September 13, 2002
The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitisCharlott Brunmark, Anna Runström, Lennart Ohlsson, et al.
Journal of Medical Genetics|July 12, 2011
Fibroblast growth factor 10 haploinsufficiency causes chronic obstructive pulmonary diseaseJoakim Klar, Peter Blomstrand, Charlott Brunmark, et al.
International Journal of Pharmaceutics|April 12, 2021
Biodistribution of fluorescence-labelled EGF protein from slow release NanoZolid depots in mouseStefan Grudén, Charlott Brunmark, Bo Holmqvist, et al.
Cell Communication and Signaling : CCS|February 7, 2025
Nano-XRF of lung fibrotic tissue reveals unexplored Ca, Zn, S and Fe metabolism: a novel approach to chronic lung diseasesBryan Falcones, Maik Kahnt, Ulf Johansson, et al.
Plos One|August 21, 2012
Transient receptor potential ankyrin 1 channel localized to non-neuronal airway cells promotes non-neurogenic inflammationRomina Nassini, Pamela Pedretti, Nadia Moretto, et al.
Pageof 1